anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
AstraZeneca · conference-presentation

AstraZeneca | Results Presentation Deck | 40 slides

40 pages · 4 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

AstraZeneca | Results Presentation Deck | 40 slides

AstraZeneca · 2021-04
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 16 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 5 slides 100% 5/5 slides 100% 5/5 slides · 20 hits
— 0/5 slides
20% 1/5 slides
— 0/5 slides
100% 5/5 slides
— 0/5 slides
Need 4 slides 100% 4/4 slides 100% 4/4 slides · 19 hits
— 0/4 slides
75% 3/4 slides 25% 1/4 slides 100% 4/4 slides
— 0/4 slides
Satisfaction 4 slides 100% 4/4 slides 100% 4/4 slides · 19 hits
— 0/4 slides
75% 3/4 slides · 4 hits 25% 1/4 slides 100% 4/4 slides
— 0/4 slides
Action 3 slides 100% 3/3 slides 100% 3/3 slides · 11 hits
— 0/3 slides
33.3% 1/3 slides
— 0/3 slides
100% 3/3 slides
— 0/3 slides

Slide inventory

40
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
other
Open slide detailBeat · Attention
04
introduce_nominees
Open slide detailBeat · Attention
05
front_matter
Open slide detailBeat · Attention
06
Includes footnotes explaining abbreviations and specific financial impacts.summarize
Open slide detailBeat · Need
07
The slide uses a table to categorize pipeline progress into regulatory approval, submission, and Phase III data readouts.summarize
Open slide detailBeat · Need
08
The slide uses a waterfall-style logic to decompose revenue growth sources.analyze_data
Open slide detailBeat · Need
09
The slide uses two side-by-side tables to compare revenue, growth percentages, and ratios across different business segments.analyze_data
Open slide detailBeat · Need
10
The slide uses a Venn-diagram-like visual to show the synergy between the two companies.summarize
Open slide detail
11
front_matter
Open slide detail
12
The slide uses stacked bar charts to visualize revenue growth over time (Q1 2018 - Q1 2021) for two pharmaceutical products.analyze_data
Open slide detail
13
Slide 13 of a conference presentation deck.analyze_data
Open slide detail
14
Includes footnotes detailing specific medical indications and market regions.analyze_data
Open slide detail
15
The slide uses stacked bar charts to show revenue composition over time (Q1 2018 - Q1 2021).analyze_data
Open slide detail
16
The chart shows revenue breakdown by product (Fasenra, Symbicort, Pulmicort, Other) from Q1 2018 to Q1 2021.analyze_data
Open slide detail
17
Includes specific market share and revenue data for Fasenra, Breztri, Lokelma, and roxadustat.analyze_data
Open slide detail
18
The slide uses a stacked bar chart to distinguish between China and EMs ex China revenue over time.analyze_data
Open slide detail
19
front_matter
Open slide detail
20
Includes footnotes regarding exchange rates, CER, and specific expense definitions.analyze_data
Open slide detail
21
The table includes a specific line item for the impact of the pandemic vaccine.analyze_data
Open slide detail
22
Includes a trend line on the bar chart and a credit rating footnote.analyze_data
Open slide detail
23
The slide uses a circular process diagram to link four strategic financial pillars.summarize
Open slide detailBeat · Satisfaction
24
The slide includes a disclaimer at the bottom regarding the exclusion of COVID-19 vaccine impact and the Alexion acquisition.summarize
Open slide detailBeat · Satisfaction
25
Includes specific financial targets ($500m synergies, double-digit growth/accretion).summarize
Open slide detailBeat · Satisfaction
26
front_matter
Open slide detailBeat · Satisfaction
27
The slide uses a three-column layout to categorize progress into clinical data, rollout, and antibody development.summarize
Open slide detail
28
The slide uses a column-based layout to map specific drug candidates to disease areas.present_solution
Open slide detail
29
The slide uses a three-column layout to show the evolution from legacy product (Synagis) to clinical trial results (Phase IIb and Phase III) for nirsevimab.present_solution
Open slide detailLoop · Before After
30
The slide uses a split-layout to contrast early-stage development (left) with late-stage/marketed assets (right).present_solution
Open slide detail
31
Memorial slide for a deceased executive.other
Open slide detail
32
Slide 32 of a presentation, likely from AstraZeneca given the drug names.summarize
Open slide detail
33
The slide uses a grid-based layout to map drug indications against patient segments and treatment lines.present_solution
Open slide detail
34
The slide uses a two-column layout to contrast early-stage pipeline assets with late-stage/marketed assets.present_solution
Open slide detail
35
The slide uses a matrix-style layout to organize pipeline events by time and event type.plan_implementation
Open slide detailLoop · Maturity Curve
36
front_matter
Open slide detail
37
The slide uses a three-column layout to summarize key business drivers.summarize
Open slide detail
38
The slide uses a stylized human head graphic with digital circuitry patterns.state_next_steps
Open slide detailBeat · Action
39
The slide lists specific drug candidates, their targets, clinical phases, indications, and expected milestones as of April 2021.summarize
Open slide detailBeat · Action
40
other
Open slide detailBeat · Action